Objective: Is there any advantages of using methylene blue in myringoplasty? To compare the results of methylene blue stained temporalis fascia graft with unstained temporalis fascia graft in underlay myringoplasty.
INTRODUCTION
Chronic suppurative otitis media (CSOM) is an inflam matory process of the mucoperiosteal lining of the middle ear cleft. Infection of the middle ear has been encountered in the humans race, since humanity itself. 1 Myringoplasty,
i.e. surgical repair of a perforated tympanic membrane is the most frequently performed otologic surgery. An adequate area of contact between graft and tympanic membrane remnant is fundamental to the successful closure of any perforation. Graft failure is considerably higher in anterior perforation, large perforation and more so by the dextrity of grafts placement. The need to clearly identify the graft is heightened more so for the trainee residents or less experienced surgeons in relation to margins of perforation, as the better a grafts is visualized, the better it will be placed to resist disruptive forces. This study was carried out to compare the results of methylene blue stained temporalis fascia graft with unstained temporalis fascia graft in myringoplasty in terms of graft uptake and gain in hearing threshold in inactive mucosal CSOM.
MATERIALS AND METHODS
In this prospective study, 120 patients of either sex in age group of 15 to 50 years with noncholesteatomatous chronic suppurative otitis media (inactive mucosal otitis media) were recruited during the period of January 2012 to January 2015 from the outpatient clinic of Otorhinolaryngology Department, Pt BD Sharma Post graduate Institute of Medical Sciences, Rohtak, India.
Patients were divided into two groups randomly: • Group I (n = 60) patients were operated by underlay myringoplasty using methylene blue stained temporalis fascia graft.
• Group II (n = 60) patients were operated by underlay myringoplasty using unstained temporalis fascia graft.
Informed consent was obtained from every patient and ethical approval was granted for the study by institutional ethical committee.
Inclusion Criteria
Patients in the age group of 15 to 50 years, uncomplicated (central) perforation of pars tensa, dry perforation for at least 4 weeks prior to surgery, absence of cholesteatoma and air bone gap more than 25 dB on pure tone audiogram.
Exclusion Criteria
Patients with history of ear surgery in the past having age < 15 years and > 50 year with conductive hearing loss > 60 dB, actively discharging ear, cholestetomatous ear, marginal or attic perforation, marked deviated nasal septum and active sinus disease.
All the patients were subjected to full history taking including onset, course, and duration of the disease, associated symptoms, previous medications, and opera tions. Patients were subjected to full otological exami nation to exclude scar of previous operation, con dition of the tympanic membrane, condition of the middle ear mucosa, tuning fork tests (Rinne's, Weber and absolute bone conduction test), and also nasal and oral examination along with Xray imaging to exclude predisposing factors like, sinusitis, tonsillitis, etc.
All patients were subjected to preoperative pure tone audiometry and it was repeated 6 months postoperatively. Routine preoperative laboratory investigation were done for all patients as required for surgery. If the ear was not already dry patients were given oral and topical antibiotics to ensure that the ear was not discharging or remained dry for at least 1 month before surgery.
All the patients were operated via permeatel or trans canal approach. The graft was harvested via horizontal incision and was spread on the slide. Then, 1 ml of 1% MB was dropped on the graft. Only one surface of the graft was stained with methylene blue. The dried stained graft was rinsed briefly with saline just before its placement to give it optimal flexibility and the graft regained bluish color as it was observed that the color of the graft got faint on drying. After usual deepithelization of margins of perfo ration, permeatel incision was given and the tym pano meatal flap was elevated.
In group I, graft was advanced with the stained side facing laterally under the tympanomeatal flap and under the malleus handle to the anterior most extent of the perforation and the edges of the graft were tucked under the margin of the drum remnant (Fig. 1) . Gelfoam soaked in antibiotic solution will be placed lateral to the tympanic membrane.
While in group II, unstained temporalis fascia graft was placed by same technique. Gelfoam soaked in anti biotic solution will be placed lateral to the tympanic membrane. Patients were operated upon by the same surgeon and all patients were followed for at least 3 months after the operation.
Postoperatively, the patients were given, tablet amoxicillin + clavulanic acid 1 gm two times a day and tablet levocetrizine 5 mg once in a day for 7 days and tablet ibuprofen 400 mg three times a day for 3 days.
Patients were discharged from the hospital after 24 hours of surgery. All the patients at the time of discharge were instructed to take adequate precautions to prevent the entry of water into the ear canal. They were advised to avoid blowing of nose and lifting heavy weights. Further followup was done on out patient basis. All the operated patients were regularly followed up for a minimum period of 6 months in the outpatient department.
On 10th postoperative day, the sutures were removed along with pack from the external auditory canal. Any evidence of infection was looked for. Patients were advised to keep the ear dry.
At 4th week, the meatus was examined for any gel foam, and if present it was removed. Condition of the graft was noted regarding takeup, residual perforation or rejection. Thereafter, the patient was followed up for 6 months until the graft uptake could be finally assessed and a pure tone audiogram was taken at the frequency of 500 Hz, 1, 2 and 4 kHz and airbone gap (ABG) was calculated.
Collection of Data and Statistical Analysis
All collected clinical sheets from the patients were revised for completeness and consistency.
Data were summarized using mean, and standard deviation for quantitative variables and frequency and percentage for qualitative ones. Comparison between groups was performed using independent sample ttest for quantitative variables and Chisquare test for qualitative ones.
Paired ttest was conducted to signify the changes in the related quantitative measurements (ABG). pvalues less than 0.05 were considered statistically significant, and less than 0.01 were considered highly significant.
The study included 120 patients who were divided randomly into two groups; group I (myringoplasty using 
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methylene blue stained temporalis fascia graft) included 60 patients where 24 were males and 36 were females. Group II (myringoplasty using unstained temporalis fascia graft) also included 60 patients where 39 were males and 21 were females. All the patients were in the age group of 15 to 50 years, 63 males and 57 females with mean age 23.04 ± 5.296 and 31.73 ± 9.0728 respectively in two groups.
The most common presenting symptoms of these patients were otorrhea and hearing loss.
In group I, patients were complaining of ear discharge for 0 to 3 years-27 (45%), 4 to 6 years-27 (45%) and 6 (10%) were complaining of ear discharge for 7 to 8 years.
In group II, 15% of cases were having ear discharges for 0 to 3 years, 50% had discharge for 4 to 6 years and 35% had discharge for 7 to 9 years (Table 1) .
Based on the pure tone audiogram, hearing loss was classified as mild (25-40 dB), moderate (41-55 dB), moderately severe (56-70 dB), severe (71-90 dB) or profound (> 90 dB).
In group I, 35% of patients were having hearing loss in the range 25 to 40 dB, 55% of patients were having hearing loss in the range 41 to 55 dB and 10% of patients were having hearing loss in the range 56 to 70 dB (Graph 1).
In group II, 90 % of patients were having hearing loss in the range of 25 to 40 dB, 10% of patients were having hearing loss in the range 41 to 55 dB (Table 2) .
Otoscopic examination was done and size of perfo ration was assessed.
Group I
Eighteen (30%) cases had subtotal perforation (grade V) whereas 27 (45%) cases had large central perforation (grade IV). Rest of the patients (25%) had medium size perforation (grade III).
Group II
Nine (15%) cases had subtotal perforation, whereas 15 (25%) cases had large central perforation. While, 60% patients had medium size perforation (Graph 2).
Follow-up Examination and Results
All patients were followed up on 10th day for suture and pack removal. Suture site and external ear were examined for any discharge or pus. In all patients, no discharge or pus was noticed on 10th day in both groups. Otoscopic findings are described in Tables 3 and 4 .
All patients presented themselves for regular follow up. Discharge was noted in six patients which resolved by change of antibiotic and only three patients had graft rejection in group I. While in group II, discharge was noted in six patients which resolved by change of antibiotic and six patients had graft rejection with residual perforation (Tables 3 and 4) .
In group I, graft uptake was 100% in both grades III and V perforations and in group II, graft uptake was 91.6% for grade III perforations and and 66.6% for grade V perforations. While in grade IV perforation, graft uptake The average preoperative ABG was 32.44 dB while the average postoperative ABG was 14.44 dB, giving an average postoperative gain of 18 dB.
Majority of patients 33 (55%) had a gain in the range of 11 to 20 dB. Eighteen patients had a gain of more than 20 dB (30%) while 18 patients (15%) had 6 to 10 dB gain (Graph 3). This group comprised of three cases with graft rejection. Mean preoperative hearing threshold was 45.69 dB with standard deviation of ± 8.95415 (median 45). Mean postoperative hearing threshold was 27.69 with standard deviation of ± 4.98806 (median 30). The average gain in hearing level was 18 dB with standard deviation of ± 7.15661 (median 15.625) ( Table 6 ).
The average preoperative ABG was 32.44 dB with standard deviation of ± 8.1865 (median 30) while the average postoperative ABG was 14.44 dB with standard deviation of ± 3.8575 (median 14.37), giving an average postoperative gain of 18 dB with standard deviation of ± 7.15661 (median 15.625) ( Table 8) .
Group II
The average preoperative hearing threshold was 37.95 dB while the average postoperative hearing threshold was 24.25 dB, thereby average gain of 13.7 dB. was 100% in both groups but there is small residual perforation in anteriorinferior quadrant region in a patient in group I (Table 5) . On applying Chisquare test, value was 4.919 with degree of freedom value 2. The pvalue was 0.0855 which was statistically insignificant.
Hearing assessment: Hearing levels were assessed at 6 months.
Group I
The average preoperative hearing threshold was 45.69 dB while the average postoperative hearing threshold was 27.69 dB. The average gain in hearing threshold was 18 dB.
The average preoperative ABG was 26.94 dB while the average postoperative gap of 13.24 dB, thereby average gain of 13.7 dB.
Majority of patients 39 (65%) had a gain in the range of 11 to 20 dB. Three patient (5%) had a gain of 0 to 5 dB while 15 patients (25%) had 6 to 10 dB gain (Graph 3). This group comprised of six cases with graft rejection. Mean preoperative hearing threshold was 37.95 with standard deviation of ± 8.0727 (median 36.25). Mean post operative hearing threshold was 24.25 dB with standard deviation of ± 7.8786 (median 22.5). The average gain in hearing level was 13.7 dB with standard deviation of ± 5.70814 (median 13.125) ( Table 7) .
The average preoperative ABG was 26.94 dB with standard deviation of ± 6.8402 (median 25) while the average postoperative ABG was 13.24 dB with standard deviation of ± 6.0227 (median 11.75), giving an average postoperative gain of 13.7 dB with standard deviation of ± 5.70814 (median 13.125) ( Table 8 ).
The statistical analyses of the data were done by applying Student ttest and mentions groups have equal variance:
pvalue for preoperative hearing threshold and ABG between both groups was 0.00667 and 0.026 respectively which was statistically significant. pvalue for postoperative hearing threshold and ABG between both groups was 0.10747 and 0.45 respectively which was statistically insignificant. pvalue was 0.04236 for gain in hearing threshold (ABG gain) between both groups which was statistically significant (Table 8) .
DISCUSSION
Myringoplasty is a procedure, in which the reconstructive procedure is limited to repair of tympanic membrane perforation. Implicit in the definition is that the ossicular chain is intact and mobile, and the middle ear is disease free.
2 Tympanic membrane repair has undergone significant refinements over the years. The anterior or subtotal tympanic membrane perforation is difficult to repair because of less vascularity; moreover, the anterior bony overhang blocks visualization. The graft may fall in the middle ear, resulting in reperforation and obliteration of the anterior part of middle ear cavity. 3 To manage these problems variety of surgical techniques, such as the use of William's microclip, sandwich graft tympanoplasty, loop overlay myringo plasty, overunderlay technique and mediolateral myringo plasty has been used.
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The prognostic factors influencing the success rate of myringoplasty are technical, including the surgical approach, the dynamics operative field and the skills of the surgeons; for example, the worst results obtained in the transmeatal approach are consequent to the more difficult positioning of the graft through this narrower operative field. Graft failure is considerably higher in anterior perforation, large perforation and possibly influenced by difference in grafts placement. Schuknecht emphasized that the surgical technique is most important variable for the success of myringoplasty. 9 Proper positioning of the graft improves the graft uptake rate. Therefore, it is very important to position the graft in the proper position by allowing the surgeon to visualize operative field better for proper handling of the graft. The need to clearly identify the graft is heightened for residents or less experienced surgeon.
Applebaum used florescene dye for determining the vascularization of the tympanic membrane to study kinetic of blood stream using xenon light source. 3 Lee (2005) used gentian violet in grafting technique in which a part of handle of malleus is exteriorized by making it pass through a stained hole created in fascia graft in overlay myringoplasty. This allows the surgeon to better see the hole and better handle the graft, it is useful regardless of the experience of the surgeon without any adverse effect of genitan violet. Such improved identi fication of a hole can be very helpful for trainee residents or less experienced surgeons and reduce the time of a graft placement and it can substantially decrease the failure rate of the grafting. 10 Talas et al (2008) advocated the use of methylene blue stained temporalis fascia and emphasized that the graft should be stained only on one side. The side receiving the pigment is brighter than unstained side. This allow the surgeon to differentiate one side from other side, making it easier to see if graft is twisted or folded. They reviewed the charts of 30 consecutive patients undergoing this technique and found the graft take up rate was 100% at the 2month followup. No patients had otherwise unexplained inner ear dysfunction attributed to the use of tissue stains. 11 We also observed the same in the present study. Vaiman et al (2010) campared the tympanoplasty results of methylene blue stained temporalis fascia graft with results of tympanoplasty using unstained temporalis fasia graft. Tympanoplasty with graft placement was performed by young surgeons on 30 patients (30 ears) with anterior perforations using intraoperative staining of tympanoplasty grafts with methylene blue (group I). The same number of patients/ears were operated by the young surgeons without intraoperative staining (group II). Results showed tympanic membrane healing (graft take) in 30 (100%) cases in group I and in 26 (86.66%) cases in group II. The puretone audiogram testing revealed significant improvement of hearing in all successful cases (p = 0.05). No side effect immediate or postponed effects were detected. They concluded that intravital staining with methylene blue in tympanoplasty simplifies the operation and could assist in better visualization and proper placement of the graft. This technique could be most useful in a training process for resident surgeons. All surgeries were perfomed by young surgeons. They reported 100% graft take up in methylene blue stained temporalis fascia graft as compared to 86.66% graft take up in unstained temporalis fascia graft. 12 Wong stated that difficulty may be experienced in the placement of the graft during tympanoplasty, especially in anterior tympanic membrane perforation. The author observed that the use of methylene blue stained temporalis fascia graft provides contrast between the edges of the tympanic membrane perforation and the graft. This contrast allows the surgeon to better visualize the graft, and thus ensures that the perforation is totally covered with the graft. 13 We also observed the same in the present study.
In this study, we used methylene blue as topical dye staining temporalis fascia graft. Our study revealed that graft success rate was 95% in group I and 85% in group II with no statistically significance in the uptake rate. There was statistically significant difference (p = 0.04) between groups I and II regarding gain in ABG postoperatively. These results are comparable with previous study in view of graft uptake and hearing improvement. 12 Addition to staining purpose, methylene blue has been used as antioxidant and antibacterial agent Hydrofera blue bacteriostatic dressing utilizes the agents: gentian violet and methylene blue to help manage wound bioburden and protect against infection in variety of etiologies that may have contributed to the wound's slow progression toward healing including diabetes, obesity, venous insufficiency, sickle cell anemia, and acute respiratory distress syndrome, acute necrotizing wound infected with methicillinresistant staphylococcus aureus (MRSA) and vancomycinresistant enterococcus. To further protect wounds from harmful microorganisms, hydrofera blue absorbs bacterialaden exudates away from the wound and does not inhibit the activity of enzymatic debriders, fibroblast growth factors, or platelet derived growth factors.
14 However, the field in patients undergoing myringoplasty is clean and almost sterile. Over the years, methylene blue has also been used in human and veterinary medicine for a number of thera peutic and diagnostic procedures. Methylene blue has been used as vital stain in conjuctival, corneal staining and for guiding layered excision in Mohs' micrographic surgery. 15 Methylene blue also has been used for staging nodal metastasis in rectal and breast carcinoma also used in diagnosis of displaced central line and abnormal parathyroid gland. 1619 It has been also used in diagnosis of uterovesical, vesicovesical fistula, parotid fistula, preauricular and brachial sinuses or fistulae.
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The advantages of using methylene blue in myringo plasty include: better visualization of the graft, proper alignment and placement of the graft in relation to margins of perforation, allowing complete closure of the perforation. The stained side is brighter than unstained side and this allows the surgeon to rule out twisting/ folding of the graft. The graft is positioned so that dyed surface faces laterally, it makes it easier to inspect the margins of perforation and the stained surface of graft allowing accurate placement of the graft, the because of better visualization of the graft. It is useful regardless of the experience of the surgeon. Such improved identification of the graft can be very helpful for trainee residents or less experienced surgeons and reduce the time of surgery. Also, methylene blue as an antioxidant and antimicrobial properties, prevents degradation and lysis of fascia graft, improves the overall success rate of graft uptake with no adverse effect.
CONCLUSION
Our study emphasizes the fact that overall satisfactory hearing outcome with adequate airbone closure and improved graft uptake in methylene blue stained temporalis fascia in myringoplasty. Although our study results are comparable with previous study in view of graft uptake and hearing improvement but long duration followup (6 month) and large data as compare to previous study values the overall outcome. Although, various modalities have been used in myringoplasty for better graft visualization as, geniton violet, formalin, alcohol and florescent dye and methylene blue. Here, we discuss the role of methylene blue as antioxidant and antimicrobial agent along with staining property that may play additional role in surgical outcome. So, methylene blue as staining agent can be practiced in routine basis to improve myringoplasty outcome among trainee residents and less experience surgeons.
